GreyWolf Therapeutics Competitors and Similar CompaniesClear all
GreyWolf Therapeutics's competitors and similar companies include Aeglea, Aptevo Therapeutics, Olema Oncology and Odyssey Therapeutics.
 GreyWolf Therapeutics GreyWolf Therapeutics is a drug discovery biotechnology company focusing on immuno-oncology. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. | |
Founding Date | Founding Date 2017 | Founding Date 2013 | Founding Date 2016 | Founding Date 2007 | Founding Date 2021 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Oxford, GB HQ Milton, GB | Locations Austin, US HQ | Locations Seattle, US HQ | Locations San Francisco, US HQ San Francisco, US | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US |
Employees | Employees 522% decrease | Employees 65117% increase | Employees 1182% decrease | Employees 9630% increase | Employees 1481% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) 4.1 m | Valuation ($) 679.2 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income ($26m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 19.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 386m |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyAptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View company